HIV treatment funds reach $2.46-B

Published by rudy Date posted on July 23, 2011

MANILA, Philippines — Funding for human immunodeficiency virus (HIV) treatment-related research and development reached an estimated $2.46 billion in 2009, according to a United Nations (UN) report which contained data collected for the first time on global investments in HIV treatment research.

The report, An Exploratory Analysis of HIV Treatment Research and Development Investments in 2009, found that of the 144 surveyed, 48 funders worldwide reported investing $2.46 billion across six HIV-related research categories—basic science, drug discovery and development, operational and implementation science, antiretroviral prevention, applied/infrastructure and HIV diagnostics.

Public-sector funders accounted for almost three-fourths of reported HIV treatment research and development spending, with the United States National Institute of Health as the leading public-sector investor worldwide in HIV treatment research and development, investing $1.6 billion in 2009.

Pharmaceutical and biotechnology companies reported investing $591 million in 2009.

However, the participation from the private sector in the survey was particularly low and the report outlines that this figure is likely to be substantially higher, possibly reaching over $1 billion.

The report was issued early this week by the Treatment Action Group, AVAC, and the Joint UN Program on HIV/AIDS (UNAIDS) at the International AIDS Society’s 6th Conference on HIV Pathogenesis, Prevention, and Treatment in Rome, Italy.

Paul De Lay, Deputy Executive Director, Programme, UNAIDS, described the data provided by the report as “a game changer for the AIDS response and will increase demand for treatment.”

“Recent scientific breakthroughs have shown that antiretroviral therapy not only saves lives, it can also prevent new infections,” De Lay said in a statement.

However, the UNAIDS official said new investments are still urgently needed to produce better, cheaper medicines to ensure the 9 million people still in need of treatment for their own health gain access and that the new demand for treatment for prevention is met.

An estimated 6.6 million people currently have access to antiretroviral treatment and a further 9 million are still in need. In a political declaration adopted at the recent United Nations High Level Meeting on AIDS in New York, UN member states committed to expanding access to treatment for 15 million people by 2015.

With new evidence showing the benefits of early initiation of HIV treatment in preventing HIV transmission, the report recommends new drug regimens be developed to be simpler, less toxic, resilient, more forgiving of treatment interruption, less prone to promote the emergence of drug resistance and have fewer complications with other drugs commonly used by people with HIV. –ROY C. MABASA, Manila Bulletin

April 2025

World Day for Safety and Health at Work
“Safety and health at work every day!”

Invoke Article 33 of the ILO constitution
against the military junta in Myanmar to carry out the 2021 ILO Commission of Inquiry recommendations against serious violations of Forced Labour and Freedom of Association protocols.
Accept National Unity Government
(NUG) of Myanmar.
Reject Military!
#WearMask #WashHands #Distancing #TakePicturesVideos

Time to support & empower survivors. Time to spark a global conversation. Time for #GenerationEquality to #orangetheworld!

Monthly Observances:

March – Women’s Role in History Month
April – Month of Planet Earth

Weekly Observances:
Last Week of March: Protection and Gender Fair Treatment of the Girl Child Week
Last Week of April – World Immunization Week

Daily Observances:
Mar 25 – International Day of Remembrance of the Victims of Slavery and the Transallantic Slave Trade
Mar 27– Earth Hour
Apr 21 – Civil Service Day
Apr 22 – World Earth Day
Apr 28 – World Day for Safety and Health at Work

Trade Union Solidarity Campaigns

No to Trafficking

Jobs! Jobs! Jobs!

Categories